J. E. Cartwright and G. S. Whitley, Strategies for investigating the maternal-fetal interface in the first trimester of pregnancy: What can we learn about pathology?, Placenta. déc, vol.60, pp.145-154, 2017.

C. Mounier-vehier, J. Amar, J. Boivin, T. Denolle, and J. Favel, Consensus d'experts HTA et Grossesse de la SFHTA, 2015.

V. Pigou, S. Magueur, and E. D. , Prise en charge du HELLP syndrome

C. Inizan, Les facteurs influençant la décision de voie d'accouchement entre 26 et 32 SA et 6 jours, 2013.

S. Valery, O. Picone, Y. Coatantiec, A. Frati, C. Labrousse et al., Prématurité modérée 34-37SA : description des causes et conséquences néonatales immédiates dans une maternité de niveau 2, Gynécologie Obstétrique Fertil. sept, vol.43, issue.9, pp.582-589, 2015.

, Collège National des Gynécologues et Obstétriciens Français, J Gynécologie Obstétrique Biol Reprod. sept, vol.34, issue.5, p.513, 2005.

B. Coulm, C. Bonnet, B. Blondel, A. Vanhaesebrouck, A. Vilain et al., , 2016.

J. Wang, Y. Zeng, Z. Ni, G. Wang, S. Liu et al., Risk factors for low birth weight and preterm birth: A population-based case-control study in Wuhan, China. J Huazhong Univ Sci Technol Med Sci, vol.37, issue.2, pp.286-92, 2017.

M. Dreyfus, P. Weber, and L. Zieleskiewicz, Morts maternelles par complications hypertensives. Résultats de l'enquête confidentielle française sur la mortalité maternelle, Gynécologie Obstétrique Fertil Sénologie. déc, vol.45, issue.12, pp.38-42, 2017.

M. Hack and E. Borawski, Outcomes in Young Adulthood for Very-Low-Birth-Weight Infants, N Engl J Med, vol.9, 2002.

L. Storme, D. Luton, L. Abdennebi-najar, L. Huërou-luron, and I. , DOHaD : conséquences à long terme de la pathologie périnatale: Retard de croissance intra-utérin et prématurité. médecine/sciences, janv, vol.32, issue.1, pp.74-80, 2016.

B. M. Sibai, M. M. Taslimi, A. El-nazer, E. Amon, B. C. Mabie et al., Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia, Am J Obstet Gynecol. 1 sept, vol.155, issue.3, pp.501-508, 1986.

B. M. Sibai, M. K. Ramadan, I. Usta, M. Salama, B. M. Mercer et al., Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome), Am J Obstet Gynecol, vol.169, issue.4, pp.1000-1006, 1993.

J. G. Santema, I. Koppelaar, and H. Wallenburg, Hypertensive disorders in twin pregnancy, Eur J Obstet Gynecol Reprod Biol. janv, vol.58, issue.1, pp.9-13, 1995.

I. Monier, B. Blondel, A. Ego, M. Kaminiski, F. Goffinet et al., Poor effectiveness of antenatal detection of fetal growth restriction and consequences for obstetric management and neonatal outcomes: a French national study, BJOG Int J Obstet Gynaecol, vol.122, issue.4, pp.518-545, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02008032

D. L. Rolnik, D. Wright, L. C. Poon, N. O'gorman, A. Syngelaki et al., Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia, N Engl J Med. 17 août, vol.377, issue.7, pp.613-635, 2017.

M. Collet, D. Luton, T. Pottecher, and V. Zupan, Prise en charge multidisciplinaire des formes graves de prééclampsie

S. Kwiatkowski, B. Do??gowska, E. Kwiatkowska, R. Rzepka, A. Torbe et al., A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth Restriction, vol.11, 2016.

T. Raia-barjat, C. Prieux, J. Gris, C. Chapelle, S. Laporte et al., Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study, J Matern Fetal Neonatal Med. 17 janv, vol.32, issue.2, pp.248-57, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01800200

I. Herraiz, E. Llurba, S. Verlohren, and A. Galindo, on behalf of the Spanish Group for the Study of Angiogenic Markers in Preeclampsia. Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/ PlGF Ratio in Singleton Pregnancies, Fetal Diagn Ther, vol.43, issue.2, pp.81-90, 2018.

P. Wu, C. Van-den-berg, Z. Alfirevic, S. O'brien, M. Röthlisberger et al., Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis. Int J Mol Sci. 23 sept, vol.16, issue.9, pp.23035-56, 2015.

P. Merviel, F. Müller, J. Guibourdenche, N. Berkane, R. Gaudet et al., Correlations between serum assays of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) and pre-eclampsia or intrauterine growth restriction (IUGR) among nulliparas younger than 38 years, Eur J Obstet Gynecol Reprod Biol. mars, vol.95, issue.1, pp.59-67, 2001.

K. R. Palmer, T. J. Kaitu'u-lino, P. Cannon, L. Tuohey, M. Silva et al., Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia, J Matern Fetal Neonatal Med. 19 mars, vol.30, issue.6, pp.635-644, 2017.

R. K. Morris, A. Bilagi, P. Devani, and M. D. Kilby, Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis, Prenat Diagn, vol.37, issue.3, pp.253-65, 2017.

, Interprétation des valeurs atypiques des marqueurs sériques, J Gynécologie Obstétrique Biol Reprod. 1 janv, vol.43, issue.1, pp.5-11, 2014.

I. Fantasia, D. Kasapoglu, T. Kasapoglu, A. Syngelaki, R. Akolekar et al., Fetal major cardiac defects and placental dysfunction at 11-13 weeks' gestation, Ultrasound Obstet Gynecol. 1 févr, vol.51, issue.2, pp.194-202, 2018.

M. Y. Tan, A. Syngelaki, L. C. Poon, D. L. Rolnik, N. O'gorman et al., Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation, Ultrasound Obstet Gynecol, vol.52, issue.2, pp.186-95, 2018.

S. Sifakis, V. P. Androutsopoulos, A. Pontikaki, A. Velegrakis, G. I. Papaioannou et al., Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR, Mol Med Rep. mai, vol.17, issue.5, pp.6435-6475, 2018.

N. Yu, H. Cui, X. Chen, and Y. Chang, First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction, Taiwan J Obstet Gynecol. juin, vol.56, issue.3, pp.358-61, 2017.

L. A. Cole, Biological functions of hCG and hCG-related molecules, Reprod Biol Endocrinol RBE. 24 août, vol.8, p.102, 2010.

P. Sirikunalai, C. Wanapirak, S. Sirichotiyakul, F. Tongprasert, K. Srisupundit et al., Associations between maternal serum free beta human chorionic gonadotropin (?-hCG) levels and adverse pregnancy outcomes, J Obstet Gynaecol. 17 févr, vol.36, issue.2, pp.178-82, 2016.

E. Keikkala, P. Vuorela, H. Laivuori, J. Romppanen, S. Heinonen et al., First trimester hyperglycosylated human chorionic gonadotrophin in serum -A marker of early-onset preeclampsia, Placenta, vol.34, issue.11, pp.1059-65, 2013.

D. L. Rolnik, D. Wright, L. Poon, A. Syngelaki, N. O'gorman et al., ASPRE trial: performance of screening for preterm pre-eclampsia, Ultrasound Obstet Gynecol, vol.50, issue.4, pp.492-497, 2017.

G. Karagiannis, R. Akolekar, R. Sarquis, D. Wright, and K. H. Nicolaides, Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11-13 Weeks, Fetal Diagn Ther, vol.29, issue.2, pp.148-54, 2011.

L. Poon, G. Karagiannis, I. Staboulidou, A. Shafiei, and K. H. Nicolaides, Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates, Prenat Diagn, vol.31, issue.1, pp.58-65, 2011.

E. Litwi?ska, M. Litwi?ska, P. Oszukowski, K. Szaflik, and P. Kaczmarek, Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers, Adv Clin Exp Med Off Organ Wroclaw Med Univ. juin, vol.26, issue.3, pp.439-487, 2017.

Y. Chang, X. Chen, H. Cui, X. Li, and Y. Xu, New Predictive Model at 11+0 to 13+6 Gestational Weeks for Early-Onset Preeclampsia With Fetal Growth Restriction, Reprod Sci. 1 mai, vol.24, issue.5, pp.783-792, 2017.

A. Spinillo, S. Cesari, S. Bariselli, C. Tzialla, B. Gardella et al., Placental lesions associated with oligohydramnios in fetal growth restricted (FGR) pregnancies, Placenta. mai, vol.36, issue.5, pp.538-582, 2015.

M. Y. Tan, L. C. Poon, D. L. Rolnik, A. Syngelaki, P. Matallana-c-de et al., Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE, Ultrasound Obstet Gynecol, vol.52, issue.1, pp.52-61, 2018.

L. C. Poon and K. H. Nicolaides, Early Prediction of Preeclampsia, Obstetrics and Gynecology International, 2014.

N. Belhomme, C. Doudnikoff, E. Polard, B. Henriot, H. Isly et al., Aspirine : indications et utilisation durant la grossesse, Rev Médecine Interne. déc, vol.38, issue.12, pp.825-857, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01659441

A. Ego, Définitions : petit poids pour l'âge gestationnel et retard de croissance intrautérin, J Gynécologie Obstétrique Biol Reprod, vol.42, issue.8, pp.872-94, 2013.

S. J. Gordijn, I. M. Beune, and W. Ganzevoort, Building consensus and standards in fetal growth restriction studies, Best Pract Res Clin Obstet Gynaecol. mai, vol.49, pp.117-143, 2018.

F. Figueras and E. Gratacos, An integrated approach to fetal growth restriction, Best Pract Res Clin Obstet Gynaecol. janv, vol.38, pp.48-58, 2017.

C. Ortiz and L. Moore, Parental Age and the Risk of Gestational Hypertension and Preeclampsia, Southern Medical Journal. Septembre, vol.111, pp.544-548, 2018.

P. A. Cavazos-rehg, M. J. Krauss, E. L. Spitznagel, K. Bommarito, T. Madden et al., Maternal Age and Risk of Labor and Delivery Complications, Matern Child Health J. 1 juin, vol.19, issue.6, pp.1202-1213, 2015.

J. Wei, C. Liu, T. Gong, Q. Wu, and L. Wu, Cigarette smoking during pregnancy and preeclampsia risk: a systematic review and meta-analysis of prospective studies, Oncotarget, vol.6, issue.41, pp.43667-78, 2015.

T. Jääskeläinen, S. Suomalainen-könig, E. Hämäläinen, K. Pulkki, J. Romppanen et al., Angiogenic profile and smoking in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort, Ann Med, vol.49, issue.7, pp.593-602, 2017.

M. Abraham, S. Alramadhan, C. Iniguez, L. Duijts, V. Jaddoe et al., A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis, PLoS ONE. Fevrier, vol.12, issue.2, 2017.

G. Smith, E. J. Stenhouse, J. A. Crossley, D. A. Aitken, A. D. Cameron et al., Early Pregnancy Levels of Pregnancy-Associated Plasma Protein A and the Risk of Intrauterine Growth Restriction, Premature Birth, Preeclampsia, and Stillbirth

R. K. Morris, A. Bilagi, P. Devani, and M. D. Kilby, Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis, Prenat Diagn, vol.37, issue.3, pp.253-65, 2017.

S. Hourrier, L. J. Salomon, S. Dreux, and F. Muller, Screening for adverse pregnancy outcome at early gestational age, Clin Chim Acta, pp.1547-52, 2010.

R. J. Levine, K. Lim, E. F. Schisterman, B. P. Sachs, B. M. Sibai et al., Circulating Angiogenic Factors and the Risk of Preeclampsia, N Engl J Med, vol.12, 2004.

K. Murtoniemi, T. Vahlberg, E. Hämäläinen, E. Kajantie, A. K. Pesonen et al., The effect of low-dose aspirin on serum placental growth factor levels in a high-risk PREDO cohort, Pregnancy Hypertens. juill, vol.13, pp.51-58, 2018.